Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Stockholders' Equity

v3.25.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Ordinary Shares
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2023 $ (6,403) $ 135 $ 454,759 $ (461,298) $ 1
Beginning balance (in shares) at Dec. 31, 2023   13,499,003      
Issuance of ordinary shares, net 7,355 $ 31 7,324    
Issuance of ordinary shares, net (in shares)   3,055,882      
Exercise of share options 29   29    
Exercise of share options, (in shares)   29,144      
Share-based compensation expense 206   206    
Net loss (12,098)     (12,098)  
Unrealized gain on available-for-sale securities (2)       (2)
Ending balance at Jun. 30, 2024 (10,913) $ 166 462,318 (473,396) (1)
Ending balance (in shares) at Jun. 30, 2024   16,584,029      
Beginning balance at Dec. 31, 2023 (6,403) $ 135 454,759 (461,298) 1
Beginning balance (in shares) at Dec. 31, 2023   13,499,003      
Net loss (24,774)        
Ending balance at Dec. 31, 2024 (4,081) $ 315 481,676 (486,072)  
Ending balance (in shares) at Dec. 31, 2024   31,534,233      
Beginning balance at Mar. 31, 2024 (6,150)   462,084 (468,399)  
Beginning balance (in shares) at Mar. 31, 2024   16,470,414      
Issuance of ordinary shares, net 109 $ 1 108    
Issuance of ordinary shares, net (in shares)   84,471      
Exercise of share options 29   29    
Exercise of share options, (in shares)   29,144      
Share-based compensation expense 97   97    
Net loss (4,997)     (4,997)  
Unrealized gain on available-for-sale securities (1)       (1)
Ending balance at Jun. 30, 2024 (10,913) $ 166 462,318 (473,396) $ (1)
Ending balance (in shares) at Jun. 30, 2024   16,584,029      
Beginning balance at Dec. 31, 2024 (4,081) $ 315 481,676 (486,072)  
Beginning balance (in shares) at Dec. 31, 2024   31,534,233      
Issuance of ordinary shares, net 11,445 $ 106 11,339    
Issuance of ordinary shares, net (in shares)   10,570,613      
Exercise of warrants for ordinary shares (in shares)   26,482      
Exercise of warrants for ordinary shares 32   32    
Share-based compensation expense 117   117    
Net loss (11,400)     (11,400)  
Ending balance at Jun. 30, 2025 (3,887) $ 421 493,164 (497,472)  
Ending balance (in shares) at Jun. 30, 2025   42,131,328      
Beginning balance at Mar. 31, 2025 (2,554) $ 357 488,052 (490,963)  
Beginning balance (in shares) at Mar. 31, 2025   35,686,616      
Issuance of ordinary shares, net 5,120 $ 64 5,056    
Issuance of ordinary shares, net (in shares)   6,444,712      
Share-based compensation expense 56   56    
Net loss (6,509)     (6,509)  
Ending balance at Jun. 30, 2025 $ (3,887) $ 421 $ 493,164 $ (497,472)  
Ending balance (in shares) at Jun. 30, 2025   42,131,328